Cargando…
Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis()
Schistosomiasis, a snail-borne parasitic disease, affects more than 200 million people worldwide. Currently the treatment of schistosomiasis relies on a single therapy of praziquantel, a drug developed over 30 years ago. Thus, there is an urgent need to develop alternative antischistosomal drugs. In...
Autores principales: | Zhang, Si-Ming, Coultas, Kristen A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638872/ https://www.ncbi.nlm.nih.gov/pubmed/23641325 http://dx.doi.org/10.1016/j.ijpddr.2012.12.001 |
Ejemplares similares
-
Sanguinarine
por: Servoss, George L.
Publicado: (1910) -
Toxicological Effects of Berberine and Sanguinarine
por: Singh, Nitika, et al.
Publicado: (2018) -
Biosynthesis of Antitumoral and Bactericidal Sanguinarine
por: García, Víctor P., et al.
Publicado: (2006) -
Antibacterial activity and mechanism of sanguinarine against Providencia rettgeri in vitro
por: Zhang, Qian, et al.
Publicado: (2020) -
Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity
por: Chisango, Tawanda J., et al.
Publicado: (2019)